VireturnRevenue
1.9B USDAnnual · FY 2025MRNA
Moderna, Inc.
Operating income
-3.1B USDAnnual · FY 2025Net income
-2.8B USDAnnual · FY 2025Total assets
12.3B USDAnnual · FY 2025Equity
8.7B USDAnnual · FY 2025Operating cash flow
-1.9B USDAnnual · FY 2025MRNA · Chart
Chart provided by TradingView. Loading the chart connects your browser to TradingView and sends necessary technical information such as your IP address, page URL, and displayed symbol.
Reported financial information
Revenue
USD
1.9B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 18.5B USD |
| FY 2022 | 19.3B USD |
| FY 2023 | 6.8B USD |
| FY 2024 | 3.2B USD |
| FY 2025 | 1.9B USD |
Operating income
USD
-3.1B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 13.3B USD |
| FY 2022 | 9.4B USD |
| FY 2023 | -4.2B USD |
| FY 2024 | -3.9B USD |
| FY 2025 | -3.1B USD |
Net income
USD
-2.8B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 12.2B USD |
| FY 2022 | 8.4B USD |
| FY 2023 | -4.7B USD |
| FY 2024 | -3.6B USD |
| FY 2025 | -2.8B USD |
Total assets
USD
12.3B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 24.7B USD |
| FY 2022 | 25.9B USD |
| FY 2023 | 18.4B USD |
| FY 2024 | 14.1B USD |
| FY 2025 | 12.3B USD |
Equity
USD
8.7B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 14.1B USD |
| FY 2022 | 19.1B USD |
| FY 2023 | 13.9B USD |
| FY 2024 | 10.9B USD |
| FY 2025 | 8.7B USD |
Operating cash flow
USD
-1.9B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 13.6B USD |
| FY 2022 | 5B USD |
| FY 2023 | -3.1B USD |
| FY 2024 | -3B USD |
| FY 2025 | -1.9B USD |
Revenue growth
%
-39.9%
Period data
| Period | Value |
|---|---|
| FY 2021 | 2,200.2% |
| FY 2022 | 4.3% |
| FY 2023 | -64.4% |
| FY 2024 | -52.7% |
| FY 2025 | -39.9% |
Operating income growth
%
Loss narrowed
Period data
| Period | Value |
|---|---|
| FY 2021 | Loss → Profit |
| FY 2022 | -29.2% |
| FY 2023 | Profit → Loss |
| FY 2024 | Loss narrowed |
| FY 2025 | Loss narrowed |
Net income growth
%
Loss narrowed
Period data
| Period | Value |
|---|---|
| FY 2021 | Loss → Profit |
| FY 2022 | -31.5% |
| FY 2023 | Profit → Loss |
| FY 2024 | Loss narrowed |
| FY 2025 | Loss narrowed |
Operating margin
%
-158.1%
Period data
| Period | Value |
|---|---|
| FY 2021 | 72% |
| FY 2022 | 48.9% |
| FY 2023 | -61.9% |
| FY 2024 | -121.9% |
| FY 2025 | -158.1% |
Net margin
%
-145.2%
Period data
| Period | Value |
|---|---|
| FY 2021 | 66.1% |
| FY 2022 | 43.4% |
| FY 2023 | -68.8% |
| FY 2024 | -110% |
| FY 2025 | -145.2% |
Return on assets
%
-21.3%
Period data
| Period | Value |
|---|---|
| FY 2021 | 76.2% |
| FY 2022 | 33.1% |
| FY 2023 | -21.3% |
| FY 2024 | -21.9% |
| FY 2025 | -21.3% |
Debt/Equity
x
0.43x
Period data
| Period | Value |
|---|---|
| FY 2021 | 0.74x |
| FY 2022 | 0.35x |
| FY 2023 | 0.33x |
| FY 2024 | 0.3x |
| FY 2025 | 0.43x |